-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Assumes Ardent Health Partners at Neutral, Announces Price Target of $20

Benzinga·12/17/2024 12:36:35
Listen to the news
JP Morgan analyst Benjamin Rossi assumes Ardent Health Partners (NYSE:ARDT) with a Neutral rating and announces Price Target of $20.